Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Sivan, Shamai"'
Autor:
Sivan Shamai, Zach Rozenbaum, Ofer Merimsky, Matthew Derakhshesh, Yonatan Moshkovits, Joshua Arnold, Yan Topilsky, Yaron Arbel, Michal Laufer-Perl
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Chemotherapy induced cardio-toxicity has been recognized as a serious side effect since the first introduction to anthracyclines (ANT). Cardio-toxicity among patients with breast cancer is well studied but the impact on patients w
Externí odkaz:
https://doaj.org/article/6727d1be104e46299a9ac8ca98dc9dc7
Autor:
Esther Osher, Eiman Shalabna, Joseph M. Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 407 (2023)
The objective of this study was to determine the prognostic value of lymph node (LN) involvement and the LN ratio (LNR) and their effect on recurrence rates and survival in patients with pancreatic neuroendocrine tumors (PNETs) undergoing surgery. Th
Externí odkaz:
https://doaj.org/article/709360edc7fa4272b9ccfd9971c2b745
Autor:
Barliz Waissengein, Bian Abu Ata, Ofer Merimsky, Sivan Shamai, Ido Wolf, Joshua H. Arnold, Tali Bar-On, Shmuel Banai, Shafik Khoury, Michal Laufer-Perl
Publikováno v:
Clinical Research in Cardiology. 112:409-418
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer; however, at the potential cost of serious adverse events including cardiac injury.To assess the baseline and longitudinal changes in high sensitivity-Troponin (hs-Tn) in
Autor:
Yasmin Leshem, Yardena Dolev, Nava Siegelmann-Danieli, Moser Sarah Sharman, Lior Apter, Gabriel Chodick, Alla Nikolaevski-Berlin, Sivan Shamai, Ofer Merimsky, Ido Wolf
Publikováno v:
Endocrine Abstracts.
Autor:
Barliz Waissengrin, Yasmin Leshem, Marwa Taya, David Meiri, Ofer Merimsky, Sivan Shamai, Ido Wolf, Tami Rubinek
Publikováno v:
European journal of cancer (Oxford, England : 1990). 180
The use of medical cannabis has rapidly increased among cancer patients worldwide. Cannabis is often administered concomitantly with cancer medications, including immune checkpoint inhibitors (ICIs). As the cannabinoid receptors are abundantly expres
Autor:
Sivan Shamai, David Hagin, Ophira Salomon, Mordechai Shohat, Sigal Fishman, Hagit Baris Feldman, Alina Kurolap, Tal Freund, Eli Brazowski, Dror Lahav
Publikováno v:
Journal of Clinical Immunology. 41:477-481
Autor:
Yael Netanyahu, Sivan Shamai, Guy Lahat, Fabian Gerstenhaber, Osnat Sher, Ofer Merimsky, Joseph M. Klausner, Eran Nizri
Publikováno v:
Annals of Surgical Oncology. 28:2693-2699
Retroperitoneal sarcoma (RPS) surgery entails multivisceral resection, which may cause postoperative complications. We assessed the effects of complications on survival to identify their predisposing factors in primary (PRPS) and recurrent (RRPS) RPS
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis
Autor:
Sivan Shamai, Benjamin Salwen, Ido Wolf, Haim Shmilovich, Zach Rozenbaum, Ofer Merimsky, Yonatan Moshkovits, Ravit Geva, Livia Kapusta, Michal Laufer-Perl, Shira Peleg Hasson, Ari Raphael, Ayelet Sivan
Publikováno v:
Clinical Research in Cardiology. 110:50-60
Immune checkpoint inhibitors (ICI) have transformed the standard care of cancer treatment. Recent case reports describe ICI-mediated myocarditis with an atypical presentation and fatal potential which lead to permanent interruption of immunotherapy.
Autor:
Sivan Shamai, Ilana Nabiochtchikov, Sarah Kraus, Sally Zigdon, Dina Kazanov, Michal Itzhak-Klutch, Carmit Eizner, Nadir Arber, Ravit Geva
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0134469 (2015)
There are no validated biomarkers that correlate with the prognosis of pancreatic ductal adenocarcinoma (PDA). The CD24 and adenomatous polyposis coli (APC) genes are important in the malignant transformation of gastrointestinal cells. This study exa
Externí odkaz:
https://doaj.org/article/a9f16e1c9d534a2087dc795699d386ef
Autor:
Mor Moskovitz, Elizabeth Dudnik, Sivan Shamai, Yakir Rotenberg, Noa Popovich-Hadari, Mira Wollner, Alona Zer, Maya Gottfried, Moshe Mishaeli, Shoshana Keren Rosenberg, Amir Onn, Ofer Merimsky, Damien Urban, Nir Peled, Natalie Maimon, Jair Bar
Publikováno v:
The oncologist. 27(1)
Objectives ALK inhibitors (ALKi) are the standard-of-care treatment for metastatic ALK-rearranged non-small cell lung cancer (NSCLC) in the first- and second-line setting. We conducted a real-world multi-institutional analysis, aiming to compare the